One major factor that prevails in every region is the rising demand for technologically advanced, optimized, and cost-effective biomanufacturing produce to enhance the production of biologic-based medicines. This extensive demand has further propelled biopharmaceutical companies as well as contract manufacturers to embrace this technology. The global next-generation biomanufacturing market is therefore perceived to be a market with high attractiveness by the investors. With the advent of COVID-19, the demand for advanced biomanufacturing increased for high precision. With the growing number of biopharmaceutical products in the pipeline and increasing approval for them, the market witnessed high growth in the last two years. Furthermore, increased funding from private investors and governments for the development of next-generation biomanufacturing facilities is expected to additionally boost the demand for next-generation biomanufacturing products. The most promising way t...